South Korea
· Delayed Price · Currency is KRW ALTEOGEN Statistics
Total Valuation
ALTEOGEN has a market cap or net worth of KRW 20.33 trillion. The enterprise value is 20.14 trillion.
| Market Cap | 20.33T |
| Enterprise Value | 20.14T |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALTEOGEN has 53.44 million shares outstanding. The number of shares has increased by 2.23% in one year.
| Current Share Class | 53.44M |
| Shares Outstanding | 53.44M |
| Shares Change (YoY) | +2.23% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 25.82% |
| Owned by Institutions (%) | 10.43% |
| Float | 39.59M |
Valuation Ratios
The trailing PE ratio is 163.22 and the forward PE ratio is 279.06.
| PE Ratio | 163.22 |
| Forward PE | 279.06 |
| PS Ratio | 134.09 |
| PB Ratio | 45.02 |
| P/TBV Ratio | 55.57 |
| P/FCF Ratio | 5,190.54 |
| P/OCF Ratio | 2,744.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 279.67, with an EV/FCF ratio of 5,140.41.
| EV / Earnings | 161.80 |
| EV / Sales | 132.79 |
| EV / EBITDA | 279.67 |
| EV / EBIT | 291.20 |
| EV / FCF | 5,140.41 |
Financial Position
The company has a current ratio of 11.58, with a Debt / Equity ratio of 0.11.
| Current Ratio | 11.58 |
| Quick Ratio | 11.32 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 12.77 |
| Interest Coverage | 34.93 |
Financial Efficiency
Return on equity (ROE) is 34.69% and return on invested capital (ROIC) is 11.38%.
| Return on Equity (ROE) | 34.69% |
| Return on Assets (ROA) | 9.35% |
| Return on Invested Capital (ROIC) | 11.38% |
| Return on Capital Employed (ROCE) | 11.27% |
| Revenue Per Employee | 978.39M |
| Profits Per Employee | 802.97M |
| Employee Count | 155 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 48.56 |
Taxes
| Income Tax | -45.13B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.04% in the last 52 weeks. The beta is 1.31, so ALTEOGEN's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +33.04% |
| 50-Day Moving Average | 364,820.00 |
| 200-Day Moving Average | 355,787.50 |
| Relative Strength Index (RSI) | 51.83 |
| Average Volume (20 Days) | 412,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALTEOGEN had revenue of KRW 151.65 billion and earned 124.46 billion in profits. Earnings per share was 2,331.25.
| Revenue | 151.65B |
| Gross Profit | 107.77B |
| Operating Income | 69.16B |
| Pretax Income | 77.71B |
| Net Income | 124.46B |
| EBITDA | 72.01B |
| EBIT | 69.16B |
| Earnings Per Share (EPS) | 2,331.25 |
Balance Sheet
The company has 329.80 billion in cash and 50.04 billion in debt, giving a net cash position of 279.76 billion or 5,234.94 per share.
| Cash & Cash Equivalents | 329.80B |
| Total Debt | 50.04B |
| Net Cash | 279.76B |
| Net Cash Per Share | 5,234.94 |
| Equity (Book Value) | 451.70B |
| Book Value Per Share | 6,910.97 |
| Working Capital | 388.07B |
Cash Flow
In the last 12 months, operating cash flow was 7.41 billion and capital expenditures -3.49 billion, giving a free cash flow of 3.92 billion.
| Operating Cash Flow | 7.41B |
| Capital Expenditures | -3.49B |
| Free Cash Flow | 3.92B |
| FCF Per Share | 73.31 |
Margins
Gross margin is 71.07%, with operating and profit margins of 45.61% and 82.07%.
| Gross Margin | 71.07% |
| Operating Margin | 45.61% |
| Pretax Margin | 51.24% |
| Profit Margin | 82.07% |
| EBITDA Margin | 47.49% |
| EBIT Margin | 45.61% |
| FCF Margin | 2.58% |
Dividends & Yields
ALTEOGEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.23% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.61% |
| FCF Yield | 0.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 25, 2022. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 25, 2022 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
ALTEOGEN has an Altman Z-Score of 50.58 and a Piotroski F-Score of 4.
| Altman Z-Score | 50.58 |
| Piotroski F-Score | 4 |